<p><span>Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independentΒ risk factor for cardiovascular vascular disease.Β Β Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of
Lipoprotein (A)
β Scribed by Angelo Scanu (Eds.)
- Publisher
- Academic Press
- Year
- 1990
- Tongue
- English
- Leaves
- 221
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Table of Contents
Content:
Front Matter, Page iii
Copyright, Page iv
Preface, Pages xi-xii, Angelo M. Scanu
Chapter 1 - Lp(a) Lipoprotein: An Overview, Pages 1-23, KΓ₯re Berg
Chapter 2 - Molecular Biology of Apolipoprotein(a), Pages 25-40, Richard M. Lawn, James E. Tomlinson, John W. McLean, Dan L. Eaton
Chapter 3 - Heterogeneity of Particles Containing the Apo B-Apo(a) Complex, Pages 41-51, Gunther M. Fless
Chapter 4 - Structural Properties of Apo(a): A Major Apoprotein of Human Lipoprotein(a), Pages 53-60,60A,61-74, Joel D. Morrisett, John W. Gaubatz, Roger D. Knapp, Juan G. Guevara Jr.
Chapter 5 - Genetics of the Lp(a) Lipoprotein, Pages 75-85, Gerd Utermann
Chapter 6 - The Structure and Activation of Human Plasminogen, Pages 87-101, Francis J. Castellino, Tetsumei Urano, Vesna S. deSerrano, John M. Beals
Chapter 7 - Lp(a) and the Fibrinolytic System, Pages 103-115, Joseph Loscalzo, Gunther M. Fless, Angelo M. Scanu
Chapter 8 - Relationship between Plasminogen Receptors and Lp(a), Pages 117-128, Edward F. Plow, Lindsey A. Miles
Chapter 9 - Lipoprotein(a) and Plasminogen: Linkage Analysis, Pages 129-139, Robert A. Hegele, Mitsuru Emi, Ray L. White, Jean-Marc Lalouel, Roger R. Williams, Lily L. Wu, Philip E. Hass, Richard M. Lawn
Chapter 10 - The Measurement of Lp(a) and Its Clinical Application, Pages 141-149, John J. Albers
Chapter 11 - Incidence of Lp(a) Lipoprotein among Populations, Pages 151-173, GΓΆsta H. DahlΓ©n
Chapter 12 - The Rhesus Monkey as a Model for the Study of Lp(a), Pages 175-181, Angelo M. Scanu, Ditta Pfaffinger
Chapter 13 - The Physiological Role of Lp(a), Pages 183-204, Gert M. Kostner
Chapter 14 - Lipoprotein(a) in PROCAM Participants and Young Myocardial Infarction Survivors, Pages 205-209, Martin Sandkamp, Gerd Assmann
Chapter 15 - Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels, Pages 211-220, H.Bryan Brewer
Index, Pages 221-226
π SIMILAR VOLUMES
Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease. Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovasc
This volume is a comprehensive collection of methods for the isolation, characterization, analysis and estimation of soluble lipoproteins. It surveys each aspect of lipoprotein technology in a critical manner which will enable the investigator to select the methods most relevant to his requirements.